Company news
Percheron Therapeutics Limited news in 2018
Percheron Therapeutics Limited's news releases, calls and decks from 2018, newest first.
Response to ASX Price and Volume Query
October 16, 2018
Full Year Statutory Accounts
August 29, 2018
First Patient Dosed in Phase II DMD Clinical Trial
August 28, 2018
ANP initiates ATL1102 Phase II clinical trial in DMD
July 15, 2018
ATL1103/atesidorsen Early Access Program Progress Update
June 14, 2018
ATL1103 Phase II trial results published in leading journal
May 23, 2018
Response to ASX Price & Volume Query
May 14, 2018
$5 Million Capital Raising Completion
May 3, 2018
Entitlement Offer Booklet
April 6, 2018
Placement Completion and Entitlement Issue
April 5, 2018
Institutional Placement and Rights Issue
April 3, 2018
ATL1102 Ethics Committee Approval for DMD
February 27, 2018
ATL1103/atesidorsen Early Access Program - Update
February 25, 2018